Daiichi Sankyo Oncology France

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in by 2020, and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular...

Cardiovascular diseases,glucose metabolic disorders,infectious diseases,cancer / oncology,immunity and allergies,and bones/joint diseases,antibody drug conjugates,anticoagulation,and adc

Daiichi sankyo oncology france operates in the Research services industry.

Daiichi sankyo oncology france's revenue is 11m - 100m

Daiichi sankyo oncology france has 11 - 50 employees.